| abstract |
The present invention relates to new beta-agonists of the general formula (I) wherein the radicals R1 to R7 have the meanings mentioned in the claims and in the specification, their tautomers, their enantiomers, their diastereosiomers, their mixtures, their prodrugs and their salts, in particular their physiologically compatible salts with inorganic or organic acids or bases, to a process for the preparation of these compounds, as well as their use as medicaments. |